Tenon Medical, Inc. (TNON)

Market Cap	7.56M
Revenue (ttm)	3.28M
Net Income (ttm)	-13.67M
Shares Out	3.14M
EPS (ttm)	-11.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,534,435
Open	2.500
Previous Close	2.800
Day's Range	2.050 - 2.569
52-Week Range	0.910 - 15.790
Beta	1.89
Analysts	Strong Buy
Price Target	16.00 (+563.96%)
Earnings Date	Mar 20, 2025

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Ga...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON
• Website: https://www.tenonmed.com

Financial Performance

In 2024, Tenon Medical's revenue was $3.28 million, an increase of 11.92% compared to the previous year's $2.93 million. Losses were -$13.67 million, -12.25% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for TNON stock is "Strong Buy." The 12-month stock price forecast is $16.0, which is an increase of 563.96% from the latest price.

Price Target

$16.0

(563.96% upside)

Analyst Consensus: Strong Buy